Desvenlafaxine Succinate
Brand name: Desvenlafaxine Succinate Er
Rank #412 of 500 drugs by total cost
$21.3M
Total Cost
257,580
Total Claims
$21.3M
Total Cost
9,770
Prescribers
$83
Cost per Claim
14,099
Beneficiaries
389,532
30-Day Fills
$2,184
Avg Cost/Provider
26
Avg Claims/Provider
About Desvenlafaxine Succinate
Desvenlafaxine Succinate (sold as Desvenlafaxine Succinate Er) was prescribed 257,580 times by 9,770 Medicare Part D providers in 2023, costing the program $21.3M. At $83 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 409 | Cephalexin (Cephalexin) | $21.4M | 2,407,718 |
| 410 | Teprotumumab-Trbw (Tepezza) | $21.4M | 389 |
| 411 | Nystatin (Nystatin) | $21.4M | 908,177 |
| 412 | Desvenlafaxine Succinate (Desvenlafaxine Succinate Er) | $21.3M | 257,580 |
| 413 | Sotorasib (Lumakras) | $21.3M | 1,188 |
| 414 | Ibuprofen (Ibuprofen) | $21.2M | 2,537,634 |
| 415 | Lubiprostone (Lubiprostone) | $21.1M | 86,987 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology